Celemics Inc. logo

Celemics Inc. (331920)

Market Closed
11 Aug, 06:30
KRX SM KRX SM
9,860. 00
-150
-1.4985%
21.84B Market Cap
- P/E Ratio
- Div Yield
22,615 Volume
- Eps
10,010
Previous Close
Add Transaction
Day Range
9,610 10,170
Year Range
2,535 19,840
Want to track 331920 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Summary

331920 closed today lower at ₩9,860, a decrease of -1.4985% from yesterday's close, completing a monthly decrease of -17.6274% or -₩2,110. Over the past 12 months, 331920 stock gained 240%.
331920 is not paying dividends to its shareholders.
The last earnings report, released on May 15, 2025, exceeded the consensus estimates by 0%. On average, the company has surpassed earnings expectations by 390.7114%, based on the last three reports.
The stock of the company had never split.
The company's stock is traded on one exchange.

331920 Chart

People also search for

Fine M-Tec Co., Ltd.
8,930
-2.5109%
Genexine Co., Ltd.
2,755
+1.2868%
TiumBio Co., Ltd.
4,950
-1.5905%
GeneOne Life Science Inc.
2,670
0%
Iljin Diamond Co. Ltd.
9,160
0%

Celemics Inc. (331920) FAQ

What is the stock price today?

The current price is ₩9,860.00.

On which exchange is it traded?

Celemics Inc. is listed on KRX SM.

What is its stock symbol?

The ticker symbol is 331920.

Does it pay dividends? What is the current yield?

It does not pay dividends to its shareholders.

What is its market cap?

As of today, the market cap is 21.84B.

Has Celemics Inc. ever had a stock split?

No, there has never been a stock split.

Celemics Inc. Profile

Life Sciences Tools & Services Industry
Healthcare Sector
- CEO
KRX SM Exchange
- ISIN
KR Country
41 Employees
- Last Dividend
- Last Split
- IPO Date

Overview

Celemics, Inc., founded in 2010 and based in Seoul, South Korea, specializes in the design, manufacture, and distribution of sequencing kits. This innovative company leverages cutting-edge technology to provide comprehensive solutions in the field of genetic analysis and sequencing. Through its broad range of products and services, Celemics aids research and clinical applications, targeting both hereditary and somatic mutations associated with cancer, among other genomic studies.

Products and Services

  • BRCA Kits:

    These kits are tailored for the precise detection of mutations within the BRCA1 and BRCA2 genes, known for their association with increased risks of breast and ovarian cancer. They provide essential tools for genetic research and screening in Oncology.

  • Somatic Mutation Cancer Kits:

    Designed for the identification of mutations that occur in somatic cells, which can lead to cancer. These kits enable researchers and clinicians to detect and study these mutations, offering insights necessary for the development of targeted therapies.

  • Hereditary Cancer Kits:

    These kits focus on the genetic variants that predispose individuals to a range of hereditary cancers. By facilitating early detection and risk assessment, they play a crucial role in preventive healthcare strategies.

  • NGS Library Preparation Kits:

    Essential for preparing samples for Next Generation Sequencing (NGS), these kits streamline the workflow by providing all required reagents and protocols. They are critical for ensuring high-quality data generation from genomic DNA or RNA samples.

  • Customized Target Enrichment Kit:

    Celemics offers tailor-made solutions with its customized target enrichment kits, which allow for the selective sequencing of specific genomic regions of interest, enhancing efficiency and reducing sequencing costs.

  • Next Generation Sequencing (NGS) Unit:

    Providing comprehensive sequencing services, Celemics facilitates the entire NGS workflow from sample preparation to data analysis, catering to the needs of academic, clinical, and research laboratories.

  • NGS-Lab Building Consulting Services:

    To support laboratories and institutions in setting up or upgrading their NGS capabilities, Celemics offers consulting services that cover laboratory design, equipment selection, workflow management, and personnel training, ensuring an optimized and efficient sequencing facility.

Contact Information

Address: Building A
Phone: 82 2 6746 8067